原子荧光光谱法测定褪黑素治疗组兔肝脏硒含量

为探讨褪黑素对实验性动脉粥样硬化兔肝脏组织中硒含量的影响,用高脂饮食复制兔动脉粥样硬化,然后给予褪黑素建立治疗组模型,获取肝脏,用硝酸、过氧化氢混合液微波消解样品,采用原子荧光光谱法测定肝脏组织中硒的含量。结果表明,正常组、高脂组和褪黑素治疗组硒在肝脏组织中质量分数分别为3.31、2.14和1.34 mg/kg。提示给予褪黑素治疗后,褪黑素治疗组的硒平均含量比高脂组的平均含量降低37.4%,所以褪黑素对肝脏硒的吸收具有明显的抑制作用。     

Application of Fourier transform infrared (FT-IR) spectroscopy combined with chemometrics for authentication of cod-liver oil

Some vegetable oils such as canola (CaO), corn (CO), soybean (SO), and walnut (WO) oils have similar color with cod liver oil (CLO), therefore, the presence of these oils was difficult to detect using naked eye. For this reason, Fourier transform infrared (FTIR) spectroscopy using horizontal attenuated total reflectance (HATR) as sampling accessory and in the combination with chemometrics was developed for detection and quantification of these vegetable oils as adulterants in CLO. The quantification of vegetable oils was carried out by using multivariate calibrations of partial least squares (PLS) and principle component regression (PCR), while the classification between pure CLO and CLOs adulterated with CaO, CO, SO, and WO was performed using discriminant analysis (DA). PLS with FTIR normal spectra was more suitable compared with PCR for quantification purposes with coefficient of determination (R²) higher than 0.99 and root mean square error of calibration (RMSEC) in the range of 0.04-0.82% (v/v). The PLS model was further used to predict the levels of these vegetable oils in independent samples for validation/prediction purpose. The root mean square error of prediction (RMSEP) values obtained were of 1.75% (v/v) (CaO), 1.39% (v/v) (CO), 1.35% (v/v) (SO), and 1.37% (v/v) (WO), respectively. The classification using DA revealed that the developed method can classify CLO and that mixed with these vegetable oils using 9 principal components.     

肝硬化患者血清微量元素与免疫功能的相关性研究

为探讨肝硬化患者血清中微量元素含量与细胞免疫功能的相关性,将70例肝硬化患者根据代偿期及失代偿期分为两组,30例健康体检者为对照组,用日立7170A型全自动生化分析仪检测了血清中的镁、铁、铜、锌含量,流式细胞技术检查了外周血CD3+、CD4+、CD8+、NK细胞。结果表明,肝硬化患者血清镁、铁、锌水平显著低于对照组;血清铜水平显著高于对照组;CD3+、CD4+、NK细胞低于正常对照组,以失代偿期改变明显。肝硬化患者血清铜水平与CD3+、CD4+、NK细胞呈负相关,血清锌水平与CD3+、CD4+、NK细胞呈正相关。提示肝硬化患者微量元素代谢异常与细胞免疫功能下降有一定的联系。     

全反式维甲酸治疗动脉粥样硬化兔肝脏微量元素含量的变化

目的探讨实验性动脉粥样硬化兔肝脏组织中zn、Fe、Cu、Mn和cr、Pb、cd含量的变化。方法用高脂饮食复制兔动脉粥样硬化模型,然后给予全反式维甲酸建立治疗组模型,获取肝脏,用硝酸、过氧化氢混合液微波消解样品,采用原子吸收光谱法测定肝脏组织中zn、Fe、Cu、Mn和Cr、Pb、cd的含量。结果高脂组肝脏组织zn、Fe、Cu、Mn和cr、Pb、cd含量分别为86．09、277．1、11．07、5．366mg／kg和115．2、286．0、210．5μg／／kg,治疗组肝脏组织zn、Fe、Cu、Mn和cr、Pb、cd含量分别为135．3、347．7、10．72、7．218mg／kg和137．3、209．4、250．2μg／kg。结论经过维甲酸治疗后,zn、Fe、Mn、Cr含量明显提高,基本达到正常组水平。     

16例原发性肝癌患者血清锌测定及分析

通过１６例原发性肝癌患者血清锌测定，结果发现：患者血清锌明显低于对照组。提示低血糖锌与原发性肝癌有关。对其关系进行了初步探讨。     

Determination of the putative cancer chemopreventive flavone tricin in plasma and tissues of mice by HPLC with UV--visible detection

AHPLC method developed and validated for the determination of tricin in human plasma published previously was cross-validated to allow measurement of the flavone tricin in plasma and tissues of mice. Blank samples of plasma, liver or intestinal mucosa were spiked with tricin at 0.5--4.0, 1.0--8.0 and 5.0--40 microg/mL, respectively. These tricin concentration ranges covered the tricin levels achieved in the mouse tissues in the dose-escalating experiments. Analysis afforded linear calibration curves with regression coefficients of >0.99. Endogenous compounds did not interfere with tricin detection when the detection wavelength was set at 355 nm, the maximum absorbance of tricin. Accuracy and precision were <15% for all concentrations in all matrices except for the precision at the lower limit of quantification (0.5 microg/mL) in mouse plasma, which was 18.4%. Consumption of diet mixed with tricin at 0.05, 0.2 or 0.5% for one week furnished steady-state levels in plasma, liver and small intestine in the 1--3 x 10(-7), 4--22 x 10(-7) and 3--46 x 10(-5) m ranges, respectively.     

原发性肝癌患者血清多种微量元素、铜蓝蛋白、T淋巴细胞测定与分析

应用ＩＣＰ－ＡＥＳ、酶氧化反应、酸性非特异性酯酶方法，对３３例原发性肝癌患者，测定血清多种微量元素、铜蓝蛋白及Ｔ淋巴细胞，分别与１７例、３６例、３４例健康者对照．原发性肝癌组血清铜ｘ±ｓ＝１９．１９±６．７０８μｍｏｌ／Ｌ）高于对照组（ｘ±Ｓ＝１４．８２±４．３７μｍｏｌ／Ｌ），血清钼（０．４３７±０．３１２μｍｏｌ／Ｌ）、锌（１５．５１±８．７７μｍｏｌ／Ｌ）、铁（２０．９７±２６．１３μｍｏｌ／Ｌ）均低于对照组铝（１．１８６±０．３１２μｍｏｌ／Ｌ）、锌（２０．９４±６．３１μｍｏｌ／Ｌ）、铁（４６．７２±２９．８９μｍｏｌ／Ｌ），Ｐ值均＜０．０５；肝癌组铜蓝蛋白（ｘ±Ｓ＝５．３８±２．３５活性单位／ｍＬ）高于对照组ｘ±Ｓ＝３．９２±０．８７活性单位／ｍＬ，Ｐ＜０．０５；Ｔ淋巴细胞（ｘ±Ｓ＝５７．７８±１１．７１活性单位／ｍＬ），低于对照组（ｘ±Ｓ＝６６．８０±１２．８２活性单位／ｍＬ），Ｐ＜０．０５．结果提示原发性肝癌微量元素代谢异常，直接影响酶系统，使自由基失控、机体内促氧化和抗氧化平衡失调，估计这一学说在肝癌的发病中起重要作用。     

痤疮患者血清锌水平及加锌治疗效果

测定了60例寻常痤疮患者和60例健康正常人血清锌浓度,结果表明,寻常痤疮患者血清中锌的浓度明显低于正常人水平。对40例寻常痤疮患者在按常规治疗的同时给予口服硫酸锌治疗一个月,加锌治疗组的治疗有效率为90％,明显高于仅按常规治疗组的有效率（75％）。     

阿托伐他汀联合缬沙坦对慢性肾炎的临床疗效分析

目的研究阿托伐他汀联合缬沙坦对慢性肾炎的临床疗效。方法以2014年1月—2016年6月慢性肾炎患者90例随机分为两组。单一药物组采用缬沙坦治疗,联合用药组采用阿托伐他汀联合缬沙坦治疗。比较两组患者慢性肾炎治疗总有效率;治疗前和治疗后患者肾功能指标、舒张压、收缩压的差异。结果联合用药组患者慢性肾炎治疗总有效率高于单一药物组,P0.05;治疗前两组肾功能指标、舒张压、收缩压比较无显著差异,P0.05;治疗后联合用药组肾功能指标、舒张压、收缩压改善幅度更大,P0.05。结论阿托伐他汀联合缬沙坦对慢性肾炎的临床疗效确切,可有效改善患者血压和肾功能,值得推广应用。